Hilton Capital Management’s Novartis NVS Stock Holding History

Hilton Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-300	Closed	-$26K	–	240
2019 Q3	$26K	Hold	300	–	–	﹤0.01%	235
2019 Q2	$27K	Sell	300 -35	-10%	-$2.96K	﹤0.01%	262
2019 Q1	$29K	Sell	335 -335	-50%	-$26.9K	﹤0.01%	263
2018 Q4	$51K	Hold	670	–	–	0.01%	174
2018 Q3	$52K	Hold	670	–	–	0.01%	189
2018 Q2	$45K	Buy	+670	New	+$46.2K	0.01%	218
2016 Q4	–	Sell	-15,686	Closed	-$1.11M	–	130
2016 Q3	$1.11M	Buy	15,686 +10,301	+191%	+$751K	0.27%	56
2016 Q2	$398K	Hold	5,385	–	–	0.13%	58
2016 Q1	$350K	Sell	5,385 -6,763	-56%	-$460K	0.11%	64
2015 Q4	$937K	Sell	12,148 -97,867	-89%	-$7.77M	0.3%	43
2015 Q3	$9.06M	Sell	110,015 -15	-0%	-$1.33K	3.11%	12
2015 Q2	$9.7M	Buy	110,030 +3,959	+4%	+$363K	2.74%	12
2015 Q1	$9.83M	Buy	106,071 +9,336	+10%	+$828K	3.48%	8
2014 Q4	$8.03M	Buy	+96,735	New	+$8.02M	2.61%	14

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Hilton Capital Management's NVS Position: Q4 2019 in Review

Hilton Capital Management sold out of Novartis (NVS) in Q4 2019, closing a stake of 300 shares — an estimated $26K sold.

Hilton Capital Management first reported a position in NVS in Q4 2014 and held it in 14 quarters. The position peaked at $9.83M in Q1 2015. 1,172 funds tracked by Wall St. Rank hold NVS as of Q4 2019.

Hilton Capital Management reported no remaining Novartis position as of Q4 2019 after selling out during the quarter.
Hilton Capital Management sold 300 Novartis shares in Q4 2019, an estimated $26K.
Hilton Capital Management first reported a position in Novartis in Q4 2014 and held it in 14 quarters.
Hilton Capital Management's Novartis position peaked at $9.83M in Q1 2015.
1,172 funds tracked by Wall St. Rank held Novartis as of Q4 2019.

Based on Hilton Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.